fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Nearly one in 10 pregnant people who get COVID will develop long COVID

Written by | 16 Jul 2024

Nearly one in 10 people who get COVID while pregnant will go on to develop long COVID, a report publishing July 11th in Obstetrics & Gynecology has found. “It was surprising to… read more.

How long COVID survivors are revolutionizing health care

Written by | 29 Mar 2024

To the world’s public health authorities, Covid-19 would be either a deadly disease for some or a simple respiratory illness for most, its symptoms clearing up in just… read more.

Positive topline results from phase II study evaluating Ampligen (rinatatolimod) for the treatment of post-COVID conditions – AIM ImmunoTech Inc

Written by | 18 Feb 2024

AIM ImmunoTech Inc. announced positive topline results from the Company’s Phase II study evaluating the efficacy and safety of Ampligen as a potential therapeutic for people with the… read more.

‘Long flu’ has emerged as a consequence similar to long COVID

Written by | 21 Dec 2023

Since the COVID-19 pandemic began, extensive research has emerged detailing the virus’s ability to attack multiple organ systems, potentially resulting in a set of enduring and often disabling… read more.

Vaccination before Covid-19 infection significantly reduces risk of long covid

Written by | 25 Nov 2023

Covid-19 vaccination prior to infection significantly reduces the risk of developing post-covid-condition (PCC), commonly known as long covid, researchers reported on Nov. 22, 2023 in The BMJ/British Medical… read more.

Do allergic conditions increase the risk of developing Long-COVID after SARS-CoV-2 infection?

Written by | 15 Nov 2023

In an analysis of published prospective studies of people of all ages with confirmed SARS-CoV-2 infection who were followed for at least 12 months, pre-existing allergic conditions were… read more.

Raising awareness of Long Covid ‘blue legs’ symptom

Written by | 16 Aug 2023

An unusual case of a Long Covid patient’s legs turning blue after 10 minutes of standing highlights the need for greater awareness of this symptom among people with… read more.

Long COVID not caused by COVID-19 immune inflammatory response, new research finds

Written by | 17 Jul 2023

Long Covid, which affects nearly two-million people in the UK1, is not caused by an immune inflammatory reaction to COVID-19, University of Bristol-led research finds.  Emerging data demonstrates that… read more.

Oxygen therapy improves heart function in patients with long COVID

Written by | 24 Jun 2023

A small, randomised trial in patients with post-COVID syndrome has found that hyperbaric oxygen therapy (HBOT) promotes restoration of the heart’s ability to contract properly. The research was… read more.

Metformin lowers risk of long COVID

Written by | 10 Jun 2023

Treatment with the diabetes drug metformin immediately after testing positive for the SARS-CoV-2 virus lowers the risk of developing long COVID by 41%. Researchers reported this finding on… read more.

Sleep apnea associated with increased risk for long COVID

Written by | 13 May 2023

Sleep apnea may significantly increase the risk for long COVID in adults, according to a study led by the National Institutes of Health’s RECOVER Initiative and supported by NYU Langone… read more.

Health researchers launch ‘first’ Long COVID resource for patients and health care professionals

Written by | 17 Mar 2023

The first resource of its kind to support those living with Long Covid and the healthcare professionals involved in their care, has been launched by experts from the… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.